Rhode Island Civil Rights Group Hosts Virtual Meeting on New Topics
Published Date: 7/3/2025
Notice
Summary
The Rhode Island Advisory Committee to the U.S. Commission on Civil Rights is holding a public Zoom meeting to chat about new topics they want to explore. This meeting is open to everyone interested in civil rights in Rhode Island and helps shape future discussions. No money changes hands, but your voice could help guide important civil rights work soon!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11873 — Notice of Public Meeting of the New Jersey Advisory Committee to the U.S. Commission on Civil Rights
The New Jersey Advisory Committee to the U.S. Commission on Civil Rights is hosting a free Zoom meeting on July 15, 2026, to talk about antisemitism and civil rights. Anyone interested can join, share their thoughts, and help shape future actions. There’s no cost to attend, but phone users should check their call plans to avoid charges.
2026-10758 — Notice of Public Meetings of the Montana Advisory Committee to the U.S. Commission on Civil Rights
The Montana Advisory Committee is hosting three public Zoom meetings this summer to hear about possible civil rights problems linked to Diversity, Equity, and Inclusion policies at Montana’s public universities. Anyone interested can join, share their thoughts, and learn what’s happening. These meetings don’t cost anything but might use phone minutes if you call in, so plan ahead!
2026-10250 — Notice of Public Meeting of the Utah Advisory Committee to the U.S. Commission on Civil Rights
The Utah Advisory Committee to the U.S. Commission on Civil Rights is holding two public Zoom meetings on June 25 and July 20, 2026, to talk about their recent report on education access for students with disabilities. Anyone interested can join, listen, and even share their thoughts during the open comment time. These meetings help make sure everyone’s voice is heard and no money changes hands for participation.
2026-08583 — Notice of Public Meeting of the Colorado Advisory Committee to the U.S. Commission on Civil Rights
The Colorado Advisory Committee to the U.S. Commission on Civil Rights is holding a public Zoom meeting on May 11, 2026, to review legal feedback on their report about antisemitism at Auraria campus in Denver. Students, staff, and community members interested in civil rights can join, comment, or send written feedback within 30 days. This meeting helps shape fair and safe campus policies without any cost to join online.
2026-08410 — Notice of Public Meeting of the Tennessee Advisory Committee
The Tennessee Advisory Committee is hosting three fun and free virtual meetings on May 13, June 9, and July 14, 2026, to brainstorm their first big project. Anyone in Tennessee interested in civil rights can join online or by phone to listen and share ideas. These meetings won’t cost you a dime, but phone users should watch out for their own call charges.
2026-08414 — Notice of Public Meeting of the Rhode Island Advisory Committee to the U.S. Commission on Civil Rights
The Rhode Island Advisory Committee to the U.S. Commission on Civil Rights is holding a public Zoom meeting on May 5, 2026, at 4 p.m. ET. Anyone interested can join to listen, share their thoughts, and learn about ongoing civil rights topics affecting Rhode Island. There’s no cost to join online, and written comments are welcome for 30 days after the meeting.
Previous / Next Documents
Previous: 2025-12409 — Prospective Grant of an Exclusive Patent License: The Development of an in vivo Anti-CD19 Chimeric Antigen Receptor (CAR) for the Treatment or Prevention of B Cell Mediated Autoimmune Diseases
The National Cancer Institute plans to give Capstan Therapeutics an exclusive license to use a new invention that helps treat or prevent B cell autoimmune diseases using a special CAR therapy. This means Capstan can develop and sell this treatment, potentially speeding up new options for patients. The deal could bring exciting medical advances and business growth starting soon.
Next: 2025-12412 — Agency Information Collection Activities; Proposed Collection; Comment Request; Administrative Procedures for Clinical Laboratory Improvement Amendments of 1988 Categorization
The FDA wants your thoughts on how they collect info about lab testing rules from the Clinical Laboratory Improvement Amendments (CLIA). Labs and related folks might see some updates, but no big money changes yet. You’ve got 60 days to share your ideas and help shape how this info is gathered!